Search Filters

Search Results

Found 4 results

510(k) Data Aggregation

    K Number
    K240746
    Date Cleared
    2024-11-20

    (246 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Q'Apel Medical, Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The Neurovascular Access System Family is indicated for the introduction of interventional devices into the peripheral and neuro vasculature. It is not intended for use in coronary arteries.

    Device Description

    The subject Neurovascular Access System Family consists of sterile, single-use catheters and accessories that are used together to facilitate the insertion and guidance of an appropriately sized interventional device into a selected vessel in the peripheral and neurovasculature. The Neurovascular Access System is comprised of the Neurovascular Access Catheter, Access Tool, Peel Away Introducer and Dilator. The Neurovascular Access System Family is offered in various lengths to accommodate physician preferences and anatomical variations. The distal end of the catheter is coated with hydrophilic coating to reduce friction during use and a radiopaque marker on the distal tip that is visible under fluoroscopy.

    AI/ML Overview

    This document is a 510(k) Summary for a medical device called the "Neurovascular Access System Family." It details the device's characteristics, intended use, and compares it to legally marketed predicate devices to demonstrate substantial equivalence.

    Here's a breakdown of the requested information based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    Test NameObjectiveTest Method / Standard or GuidanceAcceptance Criteria (Implied by "Pass")Reported Device Performance
    Visual Surface RequirementsTo demonstrate that the device meets the visual surface requirements.ISO 10555-1 2013, Section 4.4Device meets visual surface requirements.Pass
    Dimensional VerificationTo demonstrate that the device meets the dimensional requirements.ISO 10555-1 2013, Section 4.5Device meets dimensional requirements.Pass
    Liquid Leakage Under PressureTo demonstrate that the device passes the liquid leakage under pressure test.ISO 10555-1 2013, Section 4.7.1, Annex CDevice passes liquid leakage test.Pass
    Hub Aspiration Air LeakageTo demonstrate that the device passes the hub aspiration air leakage test.ISO 10555-1 2013, Section 4.7.2, Annex DDevice passes hub aspiration test.Pass
    Simulated Use and UsabilityTo demonstrate that the device passes testing specified in the simulated use test protocol. Simulated use testing includes usability assessment with multiple physicians.FDA guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions", April 2023Device passes simulated use and usability protocols.Pass
    Flex FatigueTo demonstrate that the device passes the flex fatigue test.FDA guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions", April 2023Device passes flex fatigue test.Pass
    Torque TestTo demonstrate the torque strength of the device.FDA guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" April 2023Device demonstrates adequate torque strength.Pass
    Tip DeflectionTo demonstrate that the tip deflection is comparable to the predicate device.FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" April 2023Tip deflection is comparable to predicate.Pass
    Device Removal ForcesTo demonstrate that the removal forces are comparable to the predicate device.FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions" April 2023Removal forces are comparable to predicate.Pass
    Peak Tensile Strength TestingTo demonstrate that the device passes the peak tensile strength testing including all bonds and joints.ISO 10555-1 2013, Section 4.6, Annex BDevice passes peak tensile strength testing.Pass
    Flow RateTo demonstrate that the flow rate is comparable to the predicate device.ISO 10555-1 2013: Section 4.9Flow rate is comparable to predicate.Pass
    Corrosion ResistanceTo demonstrate that the device has no visual evidence of corrosion.ISO 10555-1 2013, Section 4.5, Annex ANo visual evidence of corrosion.Pass
    RadiopacityTo demonstrate that the distal marker band is clearly visible under typical fluoroscopic imaging conditions.ISO 10555-1 2013, Section 4.2; ASTM F640-12Distal marker band is clearly visible.Pass
    Kink ResistanceTo demonstrate that shaft kink resistance is comparable to the predicate device and clinically relevant for the intended anatomical locations for use.FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions"Shaft kink resistance is comparable to predicate and clinically relevant.Pass
    Particulates and Coating IntegrityTo demonstrate the quantity and size of particles generated during simulated use are comparable to the predicates and reference devices.FDA Guidance: "Peripheral Percutaneous Transluminal Angioplasty (PTA) and Specialty Catheters - Premarket Notification (510(k)) Submissions"Particulates and coating integrity are comparable to predicates.Pass
    Dynamic BurstTo demonstrate that the device withstands dynamic burst strength.ISO 10555-1 2103, Annex GDevice withstands dynamic burst strength.Pass
    Static BurstTo demonstrate that the device passes static burst pressure as specified in the test protocol.ISO 10555-1 2013, Section FDevice passes static burst pressure.Pass
    Shelf LifeRepeated bench tests after accelerated aging to demonstrate that the device performance is maintained over the proposed shelf-life (6 months).ASTM D4332-22, ASTM D4169-22, ASTM F1980-21, ASTM F1886 / F1866M-16, ASTM 2096-11 (2019), ASTM F88/F88M:21Device performance maintained over 6-month shelf-life.Pass

    Biocompatibility Tests:

    Test NameObjective (Implied)Test Method / Standard or GuidanceAcceptance Criteria (Implied by "Results")Reported Device Performance
    CytotoxicityAssess cell toxicity.ISO 10993-5No reactivity observed.Non-cytotoxic
    SensitizationAssess potential for allergic reactions.ISO10993-10No evidence of delayed dermal contact sensitization.Non-sensitizing
    Intracutaneous ReactivityAssess localized irritation.ISO 10993-23Scores from test article extracts were acceptable (
    Ask a Question

    Ask a specific question about this device

    K Number
    K222786
    Date Cleared
    2023-08-25

    (344 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Q'Apel Medical, Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    072 Aspiration Catheter: As part of the 072 Aspiration System, the 072 Aspiration Catheter with a compatible suction pump is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease (within the internal carotid, middle cerebral - M1 and M2 segments, basilar, and vertebral arteries) within 8 hours of symptom onset. Patients who are ineligible for intravenous tissue plasminogen activator (IV t-PA therapy are candidates for treatment.

    Aspiration Tubing: As part of the 072 Aspiration System, the Aspiration Tubing is intended to connect the 072 Aspiration Catheter to a compatible suction pump.

    Device Description

    The 072 Aspiration Catheter is a single lumen, variable stiffness catheter. The catheter has a hydrophilic coating to reduce friction during use. The catheter includes radiopaque markers on the distal end for angiographic visualization and a Luer hub on the proximal end allowing attachments for flushing and aspiration. The Delivery Tool is an optional accessory for use with the 072 Aspiration Catheter and should be removed prior to aspiration. The 072 Aspiration Catheter, Delivery Tool. Rotating Hemostasis Valve, and Flow Switch are included in the package. The Aspiration Tubing is provided in a separate package. For the aspiration source, the 072 Aspiration Catheter is used in conjunction with a compatible suction pump with prespecified performance parameters that is connected using the Aspiration Tubing.

    AI/ML Overview

    Here's a breakdown of the acceptance criteria and study information for the Q'Apel Medical, Inc. 072 Aspiration System, based on the provided document:


    1. Table of Acceptance Criteria and Reported Device Performance

    The acceptance criteria are generally phrased as meeting "predetermined acceptance criteria" or specific ISO standards. The reported device performance for all bench tests and animal studies is "Pass," indicating that all samples met the defined criteria.

    Note: For bench tests, specific numerical acceptance criteria are not detailed in the provided summary, only the general statement that "All samples met the predetermined acceptance criteria." For biocompatibility, the specific numerical acceptance criteria are listed.

    Test CategoryAcceptance Criteria (as stated)Reported Device Performance
    Bench Testing
    Visual Surface RequirementDevice meets visual surface requirements.Pass
    Packaging Visual InspectionPackaging meets visual inspection.Pass
    Dimensional/Visual InspectionDevice dimensions conform to specifications.Pass
    Liquid Leakage Under PressureCatheter joint strength meets freedom from leakage requirements of ISO 10555-1:2013, Annex C.Pass
    Hub Aspiration Air LeakageDevice passes hub aspiration air leakage test of ISO 10555-1:2013, Annex D.Pass
    Simulated UseEffectiveness of device at retrieval of soft and firm clots and mechanical integrity after multiple passes.Pass
    Flex FatigueMeets minimum value per specification for multiple passes in the simulated use model.Pass
    Track and Advance ForceTest specimens meet track and advance force criteria.Pass
    Tip DeflectionTest specimens meet tip deflection forces criteria and compare favorably to predicate catheters.Pass
    TorqueNumber of revolutions to failure of the Catheter in simulated anatomy meets criteria.Pass
    Tip Elongation and CompressionTest specimens meet tip elongation and compression criteria.Pass
    Peak TensileTensile strength of catheter sections and bonds meets criteria after simulated use.Pass
    Particulates, Coating IntegrityIntegrity of hydrophilic coating evaluated after multiple insertion/withdrawal cycles, and particulates measured during simulated use compared to reference device, meet criteria.Pass
    Flow RateFlow rate through a catheter meets ISO 10555-1, Annex E.Pass
    Aspiration Flow RateAspiration flow rate through the aspiration catheter meets criteria when connected to a constant vacuum source.Pass
    Kink ResistanceTest specimen segments formed into a defined bend diameter meet kink resistance criteria.Pass
    Corrosion ResistanceNo visible corrosion immediately after Corrosion Testing procedure based on ISO 10555-1, Annex A.Pass
    RadiopacityMarker band is fluoroscopically visible.Pass
    Burst Pressure-StaticTested per ISO 10555-1:2013, Annex F, after simulated use, meets criteria.Pass
    Burst Pressure-DynamicMinimum value per specification.Pass
    Connectors for IntravascularHubs tested per ISO 80369-7.Pass
    Lumen CollapseAspiration Catheter samples meet lumen patency under maximum applied vacuum pressures.Pass
    Manual Syringe Injection Peak PressureMeasure peak pressure during manual injection of contrast media with a syringe, meets criteria.Pass
    Aspiration Tubing Bench Testing
    Dimensional/Visual InspectionAspiration Tubing meets all dimensional and visual specifications.Pass
    Tensile StrengthAspiration Tubing meets existing tensile strength specifications.Pass
    Simulated Use TestAspiration Tubing passes testing specified in the simulated use test protocol.Pass
    Resistance to Collapse and Leakage at Maximum Aspiration PressuresAspiration Tubing resistance to collapse at maximum aspiration pressure meets testing specified in the test protocol and does not show signs of leakage at maximum aspiration pressure.Pass
    Flow Switch Functionality TestingFlow Control Switch completely and immediately stops fluid flow after a specified number of ON/OFF cycles.Pass
    Biocompatibility Testing (072 Aspiration Catheter and Delivery Tool)
    Cytotoxicity - MEM ElutionThe achievement of a numerical grade greater than 2 is considered a cytotoxic effect. (Implicit acceptance: numerical grade ≤ 2)Non-cytotoxic
    SensitizationMagnusson and Kligman grades of 1 or greater in the test group generally indicate sensitization, provided grades of less than 1 are seen in control animals. If grades of 1 or greater are noted in control animals, then the reactions of test animals which exceed the most severe reaction in control animals are presumed to be due to sensitization. (Implicit acceptance: no statistically significant sensitization compared to control)Non-sensitizing
    Irritation: Intracutaneous ReactivityThe requirements of the test were met if the final test article score was ≤ 1.0.Non-irritating
    Acute Systemic ToxicityIf using five animals per group, the test article meets the requirement of the test if: 1. Two or more animals from the test group die. 2. Animal behavior, such as convulsions or prostration, occurs in two or more animals from the test group. 3. A final (end of study) body weight loss > 10% occurs in three or more animals from the test group. (Implicit acceptance: none of these conditions occurred)Non-toxic
    Material Mediated PyrogenicityThe requirements of the test were met if no rabbit showed an individual rise in temperature of 0.5 °C or more above its respective baseline temperature throughout the duration of the test.Non-pyrogenic
    ASTM Hemolysis- DirectThe positive control's mean hemolytic index above the negative control must be ≥ 5% for the direct method. The negative control must display a mean hemolytic index of
    Ask a Question

    Ask a specific question about this device

    K Number
    K230322
    Date Cleared
    2023-06-22

    (136 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Q'apel Medical, Inc.

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SelectFlex Neurovascular Access System Family is indicated for the introduction of interventional devices into the peripheral and neurovasculature.

    Device Description

    The subject SelectFlex Neurovascular Access System Family is a line extension to expand the previously cleared device (K211893) by offering a new SelectFlex III 064 Neurovascular Access Catheter with a diameter of 6F, a 6F dilator, an introducer sheath, and a 4.5F Access Tool that can be used with the catheter to access the desired anatomy. The 4.5F Access Tool is an accessory provided with the SelectFlex III 064 Neurovascular Access Catheter and is packaged in the same sterile pouch with the SelectFlex III 064 Neurovascular Access Catheter and accessories as part of the SelectFlex Neurovascular Access System Family.

    AI/ML Overview

    The provided text is a 510(k) Summary for a medical device (SelectFlex Neurovascular Access System Family) and does not describe a study that proves the device meets specific acceptance criteria in the context of an AI/human-in-the-loop diagnostic system. Instead, it describes nonclinical performance testing (bench testing) and biocompatibility testing conducted to demonstrate substantial equivalence to a legally marketed predicate device.

    Therefore, many of the requested items (e.g., sample sized for the test set in an AI study, number of experts for ground truth, MRMC study, standalone performance, training set details) are not applicable to this document.

    However, I can extract the acceptance criteria (goals) and reported performance (results) from the nonclinical performance data section.

    Here's the information based on the provided text:

    1. A table of acceptance criteria and the reported device performance

    For the SelectFlex Neurovascular Access System Family (including the SelectFlex III 064 Neurovascular Access Catheter, 6F Dilator, and 4.5F Access Tool where applicable):

    Test NameAcceptance Criteria (Goal)Reported Device Performance (Result)
    Visual Surface RequirementsTo demonstrate that the device meets the visual surface requirements.Pass: All samples met the predetermined acceptance criteria.
    Dimensional VerificationTo demonstrate that the device meets the dimensional requirements.Pass: All samples met the predetermined acceptance criteria.
    Liquid Leakage Under PressureTo demonstrate that the device passes the liquid leakage under pressure test.Pass: All samples met the predetermined acceptance criteria.
    Hub Aspiration Air LeakageTo demonstrate that the device passes the hub aspiration air leakage test.Pass: All samples met the predetermined acceptance criteria.
    Simulated Use/UsabilityTo demonstrate that the device passes testing specified in the simulated use test protocol. Simulated use testing includes usability assessment with multiple physicians.Pass: All samples met the predetermined acceptance criteria.
    Flex FatigueTo demonstrate that the device passes the flex fatigue test.Pass: All samples met the predetermined acceptance criteria.
    Inflation FatigueTo demonstrate that the device passes the inflation fatigue test.Pass: All samples met the predetermined acceptance criteria.
    Burst VolumeTo demonstrate that the device passes the burst volume test – tested to 2x the inflation volume.Pass: All samples met the predetermined acceptance criteria.
    Torque TestTo demonstrate the device's ability to rotate 720 degrees (2 full revolutions) at the proximal end.Pass: All samples met the predetermined acceptance criteria.
    Tip DeflectionTo demonstrate that the tip deflection is comparable to the predicate device.Pass: All samples met the predetermined acceptance criteria.
    Device Removal in Support and Tracking ModesTo demonstrate that the forces in both support and tracking modes are comparable to the predicate device.Pass: All samples met the predetermined acceptance criteria.
    Peak Tensile TestingTo demonstrate that the device passes the peak tensile strength testing including all bonds and joints.Pass: All samples met the predetermined acceptance criteria.
    Flow RateTo demonstrate that the flow rate is comparable to the predicate device.Pass: All samples met the predetermined acceptance criteria.
    Corrosion ResistanceTo demonstrate that the device has no visual evidence of corrosion.Pass: All samples met the predetermined acceptance criteria.
    RadiopacityTo demonstrate that the marker band is positioned at the distal tip of the catheter and is clearly visible under typical fluoroscopic imaging conditions.Pass: All samples met the predetermined acceptance criteria.
    Particulates, Coating Integrity, Lubricity, DurabilityTo demonstrate the quantity and size of particles generated during simulated use are comparable to the predicate and reference devices.Pass: All samples met the predetermined acceptance criteria.
    Static BurstTo demonstrate that the device passes static burst as specified in the test protocol.Pass: All samples met the predetermined acceptance criteria.
    Shelf LifeTo demonstrate that the device performance is maintained over the proposed shelf-life (6 months).Pass: All samples met the predetermined acceptance criteria.

    Biocompatibility Testing:

    Test NameAcceptance Criteria (Goal)Reported Device Performance (Result)Conclusion
    CytotoxicityAbsence of reactivityNo reactivity was observed with the test article at 24 and 48 hours.Non-cytotoxic
    SensitizationNo evidence of sensitizationThe test article extracts showed no evidence of delayed dermal contact sensitization in the guinea pig maximization test.Non-sensitizing
    Intracutaneous ReactivityNo irritationThe scores from test article extracts were 0 from the saline extract and 0 from the sesame seed oil extract.Non-irritant
    Acute Systemic ToxicityNo abnormal clinical signs/toxicityNo abnormal clinical signs indicative of toxicity were observed for 72 hours. All animals were alive at the end of 72 hours and body weight changes were within acceptable parameters.Non-toxic
    Material Mediated PyrogenicityNo significant temperature riseNo rabbit temperature rise ≥ 0.5 °C.Non-pyrogenic
    Hemolysis - Direct Contact and Extract MethodNon-hemolyticBlank corrected hemolytic index: 0.15, 0.13.Non-hemolytic
    Complement ActivationResults within acceptable rangeResults within acceptable range as compared to the controls.Not a Sc5b-9 complement activator
    ThrombogenicityNo adverse effects/thrombusNo adverse effects or clinical signs during test period and no thrombus score ≥ 2 for either test or control device.Non-thrombogenic

    2. Sample sized used for the test set and the data provenance
    The document does not specify sample sizes for each particular test, only stating "All samples" or providing a conclusion based on the samples tested. The data provenance is "bench testing" and "biocompatibility testing," which are laboratory-based tests of the device itself, not clinical data or data from human subjects.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts
    Not applicable. This is a medical device performance and biocompatibility study, not an AI diagnostic study relying on expert ground truth. However, for "Simulated Use/Usability," it states "usability assessment with multiple physicians," but specific numbers or qualifications are not provided.

    4. Adjudication method for the test set
    Not applicable.

    5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance
    Not applicable. No AI component is mentioned.

    6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done
    Not applicable. No AI component is mentioned.

    7. The type of ground truth used
    For nonclinical performance, the "ground truth" is defined by established engineering and material science standards (e.g., ISO 10555-1, FDA guidance documents, ASTM D4332, AAMI TIR42, ISO 10993 series for biocompatibility). The device's physical properties and interactions are measured against these objective criteria.

    8. The sample size for the training set
    Not applicable. There is no AI training set as this is a device performance study.

    9. How the ground truth for the training set was established
    Not applicable. There is no AI training set.

    Ask a Question

    Ask a specific question about this device

    K Number
    K211893
    Manufacturer
    Date Cleared
    2021-08-05

    (45 days)

    Product Code
    Regulation Number
    870.1250
    Reference & Predicate Devices
    Why did this record match?
    Applicant Name (Manufacturer) :

    Q'Apel Medical Inc

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    The SelectFlex Neurovascular Access System Family is indicated for the introduction of interventional devices into the peripheral and neurovasculature.

    Device Description

    The SelectFlex Neurovascular Access System Family consists of sterile, single-use intravascular catheters used to facilitate access to target vasculature during interventional procedures. The system is composed of a SelectFlex Neurovascular Access Catheter, a 3cc Mode Control Syringe, a 7Fr Peel Away Introducer, Luer Activated Valve and a Dilator (only for versions with a Long Hydrophilic coating to ease dermal entry). The SelectFlex Neurovascular Access Catheter comes in usable lengths of 95, 105 or 115cm. The SelectFlex Neurovascular Access Catheter has variable stiffness along its length and has a dual mode stiffness mechanism on the distal portion of the catheter that is activated by the user allowing the device to transition between tracking and support modes. The distal end of the SelectFlex Neurovascular Access Catheter comes in two options of a short hydrophilic coating length of 11.5cm or a long hydrophilic coating length of 30cm.

    AI/ML Overview

    The provided FDA 510(k) summary for the SelectFlex Neurovascular Access System Family describes non-clinical performance data (bench testing) to demonstrate substantial equivalence to a predicate device, rather than a study involving human subjects or AI performance metrics. Therefore, many of the requested elements pertaining to AI studies, ground truth establishment, expert adjudication, and MRMC studies are not applicable or cannot be extracted from this document.

    Here's the information that can be extracted and a clear indication where the requested information is not available in the document:


    1. Table of Acceptance Criteria and Reported Device Performance

    Test DescriptionAcceptance Criteria (Implied)Reported Device Performance
    Visual Surface Requirements (catheter and dilator)All samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Dimensional Verification (catheter and dilator)All samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Simulated Use/UsabilityAll samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Flexion FatigueAll samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Inflation FatigueAll samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Burst VolumeAll samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    ISO 80369-7: Small Bore Connectors for Hypodermic ApplicationsAll samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Particulate CountAll samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)
    Peak Tensile Testing (catheter and dilator)All samples meet pre-determined acceptance criteriaPASS (All samples met the pre-determined acceptance criteria)

    Note: The document states "All samples met the pre-determined acceptance criteria" for each test, implying that the acceptance criteria were defined prior to testing, but the specific quantitative or qualitative criteria for each test (e.g., maximum allowable particulate count, specific tensile strength values, specific pass/fail conditions for visual inspection) are not explicitly detailed in this summary.

    2. Sample size used for the test set and the data provenance

    The document does not specify the exact sample size for each bench test beyond "All samples." It states "Simulated use testing includes a usability assessment with multiple physicians" but does not give a number for the physicians or the number of simulated cases.

    Data Provenance: The data is from non-clinical bench testing and simulated use conditions, not from human clinical data or retrospective/prospective studies on patient data.

    3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts

    Not applicable. This is not an AI performance study requiring ground truth established by experts. For the "Simulated Use/Usability" test, it mentions "multiple physicians," but their specific number or qualifications are not provided as they are assessing usability, not establishing ground truth on patient data.

    4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

    Not applicable. This is not an AI performance study requiring adjudication of expert readings.

    5. If a multi-reader, multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

    No MRMC comparative effectiveness study was done. This document describes the substantial equivalence of a physical medical device (catheter system) based on bench testing, not an AI software.

    6. If a standalone (i.e. algorithm only without human-in-the loop performance) was done

    Not applicable. This document does not describe an AI algorithm.

    7. The type of ground truth used (expert consensus, pathology, outcomes data, etc)

    Not applicable. For the non-clinical bench tests, "ground truth" would be objective measurements against engineering specifications and industry standards (e.g., ISO 10555-1: 2013, ISO 80369-7) rather than clinical ground truth types like pathology or expert consensus.

    8. The sample size for the training set

    Not applicable. This document does not describe an AI system that requires a training set.

    9. How the ground truth for the training set was established

    Not applicable. This document does not describe an AI system.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1